Małecka-Panas E - Search Results

1

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study.

Fichna J, Wood JT, Papanastasiou M, Vadivel SK, Oprocha P, Sałaga M, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Krajewska WM, Kościelniak P, Makriyannis A, Storr MA. Fichna J, et al. PLoS One. 2013 Dec 27;8(12):e85073. doi: 10.1371/journal.pone.0085073. eCollection 2013. PLoS One. 2013. PMID: 24386448 Free PMC article. Clinical Trial.

2

Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.

Zielińska M, Chen C, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Małecka-Panas E, Wlaź P, Krajewska WM, Fichna J. Zielińska M, et al. J Pharm Pharmacol. 2015 Feb;67(2):244-54. doi: 10.1111/jphp.12335. Epub 2014 Dec 17. J Pharm Pharmacol. 2015. PMID: 25515402

3

Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS.

Fichna J, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Cenac N, Sałaga M, Timmermans JP, Vergnolle N, Małecka-Panas E, Krajewska WM, Storr M. Fichna J, et al. Neurogastroenterol Motil. 2014 Nov;26(11):1539-50. doi: 10.1111/nmo.12390. Epub 2014 Jul 15. Neurogastroenterol Motil. 2014. PMID: 25041572

4

FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS.

Mosińska P, Jacenik D, Sałaga M, Wasilewski A, Cygankiewicz A, Sibaev A, Mokrowiecka A, Małecka-Panas E, Pintelon I, Storr M, Timmermans JP, Krajewska WM, Fichna J. Mosińska P, et al. Neurogastroenterol Motil. 2018 May;30(5):e13272. doi: 10.1111/nmo.13272. Epub 2017 Dec 20. Neurogastroenterol Motil. 2018. PMID: 29266569

5

Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases.

Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Storr M, Kordek R, Małecka-Panas E, Krajewska WM, Fichna J. Sobczak M, et al. J Pharmacol Exp Ther. 2014 Mar;348(3):401-9. doi: 10.1124/jpet.113.209825. Epub 2013 Dec 17. J Pharmacol Exp Ther. 2014. PMID: 24345466

6

Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases.

Sobczak M, Zakrzewski PK, Cygankiewicz AI, Mokrowiecka A, Chen C, Sałaga M, Małecka-Panas E, Kordek R, Krajewska WM, Fichna J. Sobczak M, et al. Pharmacol Rep. 2014 Oct;66(5):741-50. doi: 10.1016/j.pharep.2014.03.007. Epub 2014 Apr 4. Pharmacol Rep. 2014. PMID: 25149976

7

Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome.

Jacenik D, Cygankiewicz AI, Fichna J, Mokrowiecka A, Małecka-Panas E, Krajewska WM. Jacenik D, et al. Mol Cell Endocrinol. 2018 Aug 15;471:89-96. doi: 10.1016/j.mce.2017.07.036. Epub 2017 Jul 31. Mol Cell Endocrinol. 2018. PMID: 28774781

8

Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system.

Salaga M, Binienda A, Piscitelli F, Mokrowiecka A, Cygankiewicz AI, Verde R, Malecka-Panas E, Kordek R, Krajewska WM, Di Marzo V, Fichna J. Salaga M, et al. Biochem Pharmacol. 2019 Mar;161:37-51. doi: 10.1016/j.bcp.2019.01.001. Epub 2019 Jan 3. Biochem Pharmacol. 2019. PMID: 30611738

9

Colonic inflammation induces changes in glucose levels through modulation of incretin system.

Zatorski H, Salaga M, Zielińska M, Mokrowiecka A, Jacenik D, Krajewska WM, Małecka-Panas E, Fichna J. Zatorski H, et al. Among authors: malecka panas e. Pharmacol Rep. 2021 Dec;73(6):1670-1679. doi: 10.1007/s43440-021-00327-y. Epub 2021 Sep 17. Pharmacol Rep. 2021. PMID: 34535873 Free PMC article.

10

Transient receptor potential vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment?

Fichna J, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Janecka A, Krajewska WM, Storr MA. Fichna J, et al. Neurogastroenterol Motil. 2012 Nov;24(11):e557-60. doi: 10.1111/j.1365-2982.2012.01999.x. Epub 2012 Aug 10. Neurogastroenterol Motil. 2012. PMID: 22882778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters